MAAT PHARMA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.32 EUR | +0.22% |
|
+6.64% | +33.52% |
Chart calendar MaaT Pharma
7a6d1e751e9aa1d89681a99.9sqsUP7MfFEAH-CQJBNzNOE2V4pLMwoUQZ4KWgHzqzo.sfrgOpiDRGZifqr8EnICctROIb8valNGeKs_GGWQmFyXmeAeibYdPzZ11A~e3b2a6fe7d8e2e17b7809ac0ca1b5a54
Upcoming events on MaaT Pharma
Past events on MaaT Pharma
| 2024-04-16 | European Society for Blood and Marrow Transplantation Meeting |
| 2024-04-14 | Van Lanschot Kempen Life Sciences Conference |
| 2024-04-13 | European Bone Marrow Transplant Meeting |
| 2024-04-10 12:00 | American Association for Cancer Research Meeting - Abstract Number: 6687 |
| 2024-03-28 13:00 | Q4 2023 Earnings Release |
| 2024-01-07 | Investor meeting |
| 2023-12-18 12:00 | Business Update Call |
| 2023-12-11 18:00 | American Society of Hematology Meeting - Poster number: 4947 |
| 2023-12-10 18:00 | American Society of Hematology Meeting - Poster number: 3553 |
| 2023-11-14 | Francophone Society of Marrow Transplantation and Cellular Therapy Congress |
| 2023-11-13 | Investor meeting |
| 2023-11-09 12:30 | Q3 2023 Sales and Revenue Release |
| 2023-10-31 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1321 |
| 2023-10-31 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1304 |
| 2023-10-08 | Investor Access Event |
| 2023-10-03 | KBC Securities Life Sciences Conference |
| 2023-10-03 | Portzamparc Biotech & Health Seminar |
| 2023-09-26 | LPB Regional Values Forum |
| 2023-09-26 12:00 | Q2 2023 Earnings Release |
| 2023-07-27 12:00 | Q2 2023 Sales and Revenue Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,14 | 0,97 1,20 -19% | 2,23 5,00 -55.44% | 4,00 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | -8,57 -16,1 46.8% | -19,1 -22,8 16.35% | -29,0 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | -19,9 -23,1 13.67% | -29,5 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | -19,7 -23,3 15.38% | -29,0 |
|
Net income Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | -19,7 -23,3 15.38% | -29,6 |
|
EPS EUR | Released Forecast Spread | -25,7 | 0,00 0,00 - | -1,70 -2,37 28.27% | -2,55 |
| Announcement Date | 04/10/21 | 14/04/22 | 28/03/24 | - |
| Today 11:00 | GENMAB A/S: Q1 2024 Earnings Release |
| Today 16:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-05 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 2024-05-05 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | BIONTECH SE: Q1 2024 Earnings Release |
| 2024-05-06 07:00 | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 16:01 | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
Past sector events for MaaT Pharma
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MAAT Stock
- Calendar MaaT Pharma
